EP 2197423 A1 20100623 - IMPROVED PHARMACEUTICAL COMPOSITION CONTAINING A SELECTIVE ESTROGEN RECEPTOR MODULATOR AND METHOD FOR THE PREPARATION THEREOF
Title (en)
IMPROVED PHARMACEUTICAL COMPOSITION CONTAINING A SELECTIVE ESTROGEN RECEPTOR MODULATOR AND METHOD FOR THE PREPARATION THEREOF
Title (de)
VERBESSERTE PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT EINEM SELEKTIVEN ÖSTROGEN-REZEPTOR-MODULATOR UND VERFAHREN ZU SEINER HERSTELLUNG
Title (fr)
COMPOSITION PHARMACEUTIQUE AMÉLIORÉE CONTENANT UN MODULATEUR DE RÉCEPTEUR STROGÈNE SÉLECTIF, ET PROCÉDÉ DE PRÉPARATION DE CELUI-CI
Publication
Application
Priority
EP 2007008955 W 20071016
Abstract (en)
[origin: WO2009049643A1] The present invention relates to a pharmaceutical formulation of solid dosage forms comprising a therapeutically effective amount of a selective estrogen receptor modulator, and especially Raloxifene or a pharmaceutical acceptable salt thereof, in combination with a super disintegrant such as Primojel, and a process for the preparation thereof by wet granulation.
IPC 8 full level
A61K 9/16 (2006.01); A61K 9/26 (2006.01); A61K 9/36 (2006.01); A61K 9/48 (2006.01); A61K 31/4535 (2006.01)
CPC (source: EP US)
A61K 9/2009 (2013.01 - EP US); A61K 9/2054 (2013.01 - EP US); A61K 9/2059 (2013.01 - EP US); A61K 9/2813 (2013.01 - EP US); A61K 9/2866 (2013.01 - EP US); A61K 31/4535 (2013.01 - EP US); A61P 19/10 (2018.01 - EP)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK RS
DOCDB simple family (publication)
WO 2009049643 A1 20090423; CA 2696984 A1 20090423; CA 2696984 C 20130423; EP 2197423 A1 20100623; EP 2197423 B1 20141203; US 2011065751 A1 20110317; ZA 201003379 B 20110428
DOCDB simple family (application)
EP 2007008955 W 20071016; CA 2696984 A 20071016; EP 07819025 A 20071016; US 73954510 A 20101124; ZA 201003379 A 20100513